Astellas Pharma Inc. (ALPMY) announced earnings for its full year that Increased, from the same period last year
The company's earnings came in at JPY291.535 billion, or JPY162.22 per share. This compares with JPY50.747 billion, or JPY28.24 per share, last year.
The company's revenue for the period rose 11.9% to JPY2.139 trillion from JPY1.912 trillion last year.
Astellas Pharma Inc. earnings at a glance (GAAP) :
-Earnings: JPY291.535 Bln. vs. JPY50.747 Bln. last year.-EPS: JPY162.22 vs. JPY28.24 last year.-Revenue: JPY2.139 Tn vs. JPY1.912 Tn last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.